Lantern Pharma Ownership | Who Owns Lantern Pharma?

Lantern Pharma Ownership Summary

Lantern Pharma is owned by 23.21% institutional investors, 20.28% insiders, and 56.51% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 7.93% of LTRN shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.65% of its assets in Lantern Pharma shares.

LTRN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lantern Pharma	23.21%	20.28%	56.51%
Sector	Healthcare Stocks	244.37%	12.11%	-156.48%
Industry	Biotech Stocks	379.01%	11.75%	-290.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bios capital management, lp	864.43K	7.93%	$1.18M
Vanguard group	384.04K	3.54%	$1.16M
Cm management	250.00K	2.29%	$342.50K
Renaissance	116.00K	1.06%	$158.92K
Geode capital management	111.65K	1.02%	$152.98K
Westside investment management	50.05K	0.46%	$68.57K
Vanguard fiduciary trust	49.61K	0.46%	$67.96K
Newedge advisors	47.28K	0.44%	$205.67K
Blackrock funding, inc. /de	45.27K	0.42%	$62.02K
Blackrock	39.84K	0.37%	$186.06K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bios capital management, lp	864.43K	2.24%	$1.18M
Cm management	250.00K	0.29%	$342.50K
Westside investment management	50.05K	0.01%	$68.57K
Newedge advisors	47.28K	0.00%	$205.67K
Horizon kinetics asset management	26.37K	0.00%	$36.13K
Davenport	23.81K	0.00%	$32.63K
Renaissance	116.00K	0.00%	$158.92K
Cibc private wealth group	15.43K	0.00%	$46.76K
Tower research capital llc (trc)	3.57K	0.00%	$4.89K
Two sigma investments, lp	16.04K	0.00%	$69.78K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard fiduciary trust	49.61K	-	49.61K
Cm management	250.00K	0.29%	25.00K
Blackrock	39.84K	-	20.18K
Two sigma investments, lp	16.04K	0.00%	16.04K
Cibc private wealth group	15.43K	0.00%	15.43K

Top Sellers

Holder	Shares	% Assets	Change
Bios capital management, lp	864.43K	2.24%	-145.07K
Voss capital	-	-	-50.00K
Perigon wealth management	-	-	-39.39K
Redmond asset management	-	-	-37.27K
Citadel advisors	-	-	-32.90K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	49.61K	-	49.61K	$67.96K
Two sigma investments, lp	16.04K	0.00%	16.04K	$69.78K
Cibc private wealth group	15.43K	0.00%	15.43K	$46.76K
Millennium management	10.13K	-	10.13K	$47.33K
Vanguard global advisers	2.35K	-	2.35K	$3.23K

Sold Out

Holder	Change
Qube research	-2.00
Citigroup	-45.00
Federated hermes	-74.00
Jpmorgan chase	-97.00
Cypress capital	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	39	18.18%	2,882,855	37.50%	23	6.68%	21	50.00%	8	-11.11%
Mar 31, 2026	32	-8.57%	2,069,248	-9.26%	18	4.29%	14	7.69%	8	-11.11%
Dec 31, 2025	7	-78.13%	681,528	-70.17%	6	1.40%	-	-100.00%	3	-62.50%
Sep 30, 2025	7	-78.79%	492,542	-78.02%	4	1.06%	1	-94.74%	2	-60.00%
Jun 30, 2025	33	-	2,240,755	-7.55%	20	4.11%	17	30.77%	6	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Morn Total Stk Mkt Idx Investor	338.38K	2.65%	87.75K
Vanguard MStar Total Stk Mkt Idx Invest	338.38K	2.65%	-
Vanguard Total Stock Mkt Idx Inv	338.38K	2.65%	87.75K
Vanguard US Total Market Shares ETF	256.11K	2.37%	-
Vanguard Institutional Extnd Mkt Idx Tr	81.90K	0.64%	-
Fidelity Extended Market Index	45.10K	0.35%	-2.52K
Abante Quant Value FI	35.39K	0.28%	35.39K
DFA US Targeted Value I	21.64K	0.20%	-
iShares Micro-Cap ETF	21.23K	0.19%	-
Horizon Kinetics Medical ETF	23.95K	0.19%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 12, 2026	Schalop Lee Troy	-	Buy	$100.00K
May 12, 2026	Schalop Lee Troy	-	Sell	$110.19K
May 12, 2026	KEYSER D JEFFREY	-	Sell	$110.19K
May 12, 2026	KEYSER D JEFFREY	-	Buy	$100.00K
Jun 13, 2025	Fletcher Aaron G.L.	-	Sell	$13.45K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	4	-
2026 Q1	-	-
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	70

LTRN Ownership FAQ

Who Owns Lantern Pharma?

Lantern Pharma shareholders are primarily institutional investors at 23.21%, followed by 20.28% insiders and 56.51% retail investors. The average institutional ownership in Lantern Pharma's industry, Biotech Stocks , is 379.01%, which Lantern Pharma falls below.

Who owns the most shares of Lantern Pharma?

Lantern Pharma’s largest shareholders are Bios capital management, lp (864.44K shares, 7.93%), Vanguard group (384.04K shares, 3.54%), and Cm management (250K shares, 2.29%). Together, they hold 13.77% of Lantern Pharma’s total shares outstanding.

Does Blackrock own Lantern Pharma?

Yes, BlackRock owns 0.37% of Lantern Pharma, totaling 39.84K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 186.06K$. In the last quarter, BlackRock increased its holdings by 20.18K shares, a 102.66% change.

Who is Lantern Pharma’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Lantern Pharma’s biggest shareholder by percentage of total assets invested, with 2.24% of its assets in 864.44K Lantern Pharma shares, valued at 1.18M$.

Who is the top mutual fund holder of Lantern Pharma shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Lantern Pharma shares, with 2.65% of its total shares outstanding invested in 338.38K Lantern Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools